![logo](/logos/RPGLIFE.NS.webp)
RPG Life Sciences Limited
NSE:RPGLIFE.NS
2,319.9 (INR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | RPG Life Sciences Limited |
Symbool | RPGLIFE.NS |
Munteenheid | INR |
Prijs | 2,319.9 |
Beurswaarde | 38,368,826,100 |
Dividendpercentage | 0.82% |
52-weken bereik | 1,138.55 - 2,398.3 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yugal Kishor Choturam Sikri |
Website | https://www.rpglifesciences.com |
An error occurred while fetching data.
Over RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)